1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) (Forecasted) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This forecasted Notice of Funding Opportunity (NOFO) aims to support multidisciplinary research to accelerate a Hepatitis B (HBV) cure in people living with HIV (PLWH) and HBV.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute of Allergy and Infectious Diseases (NIAID)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) - Federal Grant Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) The summary for the Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants. com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact .
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed): The purpose of this Notice of Funding Opportunity (NOFO) is to support research to better understand the impact of host and viral heterogeneity on pathogenesis of disease, viral persistence and immunopathology of Hepatitis B (HBV) and inform cure strategies for HBV in people living with HIV (PLWH).
Applicants will establish multidisciplinary teams that span the clinical and basic/translational research arenas and establish an observational cohort to accelerate discovery and increase clinical impact.
Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) National Institutes of Health (HHS-NIH11) Funding Opportunity Number: Current Application Deadline: Original Application Deadline: Maximum Federal Grant Award: Minimum Federal Grant Award: Expected Number of Awards: Cost Sharing or Matching: Applicants Eligible for this Grant State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement https://grants. nih. gov/grants/guide/rfa-files/RFA-AI-23-057.
html Grant Announcement Contact See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants • Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) • NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) • NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) • NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) • Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) • Center for HIV/AIDS Vaccine Immunology (CHAVI) • Genomics of Transplantation Cooperative Research Program • Asthma and Allergic Diseases Cooperative Research Centers More Grants from the National Institutes of Health • Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial...
• Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VC... • Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) • Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal ... • PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine...
Federal Grants by Category Grants for Single Mothers Small Business Grants for Women Federal Grants for College Federal Tuition Assistance
According to the current listing, eligibility includes: County governments; State governments; Federally recognized Native American tribal governments; Public and Indian housing authorities; Small businesses; For-profit organizations other than small businesses; Private inst…. Confirm the full requirements in the official notice before applying.
The current listing shows $8,000,000 (Award per project). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 19, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) (Forecasted) is funded by National Institute of Allergy and Infectious Diseases (NIAID). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
DoD Multidisciplinary Research Program of the University Research Initiative (MURI) is sponsored by Department of Defense (DoD) - Office of Naval Research (ONR). The Multidisciplinary Research Program of the University Research Initiative (MURI), administered by the Department of Defense Office of Naval Research, supports basic research in science and engineering at U. S.
The FY2026 Department of Defense Multidisciplinary University Research Initiative (MURI) program supports basic research in science and engineering at U.S. institutions of higher education, with emphasis on multidisciplinary research where more than one traditional discipline interacts. The Army, Navy, and Air Force basic research offices are seeking applications across 22 topic areas including artificial intelligence and autonomy, information sensing and processing, and systems manipulation. MURI grants typically provide $1.25 million to $1.5 million per year for three years with option to extend two additional years. Approximately $170 million in total funding is available annually across all topics. The program is administered through the Office of Naval Research (ONR), Army Research Office (ARO), and Air Force Office of Scientific Research (AFOSR).